Filing Details
- Accession Number:
- 0001209191-18-027116
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-01 16:39:38
- Reporting Period:
- 2018-04-30
- Accepted Time:
- 2018-05-01 16:39:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1035354 | Eloxx Pharmaceuticals Inc. | ELOX | Services-Commercial Physical & Biological Research (8731) | 841368850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1726027 | Gilad Shabtai | C/O Eloxx Pharmaceuticals, Inc. 950 Winter Street, 4Th Floor North Waltham MA 02451 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-04-30 | 75,000 | $9.75 | 3,351,770 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects the purchase of shares in the follow-on offering of Common Stock of Eloxx Pharmaceuticals, Inc. that closed on April 30, 2018.
Billionaire Hedge Funds
